rais price target post result mark solid
core trend strong volum on-going oper improv ep
beat expect confluenc factor increasingli tip field toward
high qualiti low cost scale provid environ see
on-going move toward value-bas care addit consum centric
effort encourag financi flexibl high pama remain
headwind think on-going pressur creat share gain acceler
 opportun rais pt ep prior
impact pama weigh
reimburs payor increasingli look low cost high qualiti
care continu view scale sophist provid like
best posit like beneficiari on-going share gain opportun
addit see sever factor pln increas transparency/
author waiver increasingli tip field toward larg
independ signific discrep rate hospit out-of-
network garner focu inher share shift tailwind coupl
expand access best access decad help drive overal
organ volum growth strhe ahead
estim compani see revenu volum growth across
major health plan custom except aetna open network
includ labcorp lh buy expect acceler
back half given launch buy prefer
lab network pln expect inclus value/risk base program
posit view well posit given strong data
analytics/it capabl high qualiti metric rel cost advantag
compani also indic addit health plan interest concern option
incorpor value/risk base program help control payor patient
cost see potenti benefit aforement industri dynam
expect increas transpar aid patient concess real-
time estim rise pressur competitor medicar
commerci drive acceler share gain uptick
tr target
adjust non-control interest equiti
earn jv
strong result revenu come ahead
estim consensu better expect volum trend
requisit growth vs strhe off-set lower
revenue/requisit vs strhe bp come pama
would highlight organ volum growth acceler
came ahead think despit drag exit hand
region low margin contract revenu beat coupl better expect margin
vs strhe driven benefit restructur effort complet
cost savings/oper improv initi progress manag continu expect
deliv cost effici despit higher tax rate share count adjust ep
came two cent ahead estim consensu
healthcar cost increasingli shift consum maxim consum experi
improv patient access remain core initi quest digit tool myquest
mobil app regist user improv patient conveni
time estim increas transpar reduc patient concess drive improv oper
effici also continu like quest direct product given rel cost conveni
on-going new test rollout expect interest remain high addit compani continu
advanc retail strategi safeway/walmart nr locat psc
retail-lik locat increas conveni reson patient locat
hit new volum high june compani target psc locat
retail-lik set time
solid nudg estim rais cffo
came bit estim manag reiter full year cffo
capital-expenditure guidanc respect addit compani complet
share repurchas expect buy-back activ continu back
half year final pama pressur weigh continu see sizabl a/shar gain
opportun solid cash flow trend clean balanc sheet view well posit
capit bump full year adjust ep estim
trade ep rate unchang howev
rais target reflect increas convict core trend acceler volum
page
servic
revenu
revenu
amort intang
revenu
equiti earn jv net tax
page
base teterboro nj lead provid diagnost test inform
relat servic compani offer patient physician access diagnost laboratori
servic nation network region laboratori patient servic center
addit rapid respons laboratori compani also offer esoter test includ gene-
base test substanc abus test anatom patholog servic at-hom test test
clinic lab remain integr part healthcar deliveri model diagnost test critic
compon treatment decis process continu like market view
well posit given scale like share gain acceler difficult reimburs
environ industri pressur grow patient pay sluggish core volum unlik
meaning abat near-term view risk/reward balanc
valuat risk
price target base trade adjust ep premium
current multipl view appropri upsid risk rate price target upsid
includ acceler volum growth improv price potenti accret downsid
risk includ deceler volum increas denial/pati concess stronger anticip
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
